NasdaqGS:IMI

Stock Analysis Report

Executive Summary

Intermolecular, Inc. engages in the development of advanced materials using high productivity combinatorial (HPC) technology platform for the semiconductors, consumer electronics, automotive, and aerospace industries worldwide.

Snowflake

Fundamentals

Flawless balance sheet with high growth potential.

Share Price & News

How has Intermolecular's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

1.3%

IMI

3.0%

US Semiconductor

1.8%

US Market


1 Year Return

-0.4%

IMI

20.6%

US Semiconductor

7.3%

US Market

Return vs Industry: IMI underperformed the US Semiconductor industry which returned 20.6% over the past year.

Return vs Market: IMI underperformed the US Market which returned 7.3% over the past year.


Shareholder returns

IMIIndustryMarket
7 Day1.3%3.0%1.8%
30 Day1.3%-0.02%-0.7%
90 Day2.1%4.7%0.06%
1 Year-0.4%-0.4%22.9%20.6%9.7%7.3%
3 Year19.5%19.5%82.2%71.5%46.3%36.9%
5 Year-49.4%-49.4%137.4%112.9%64.5%46.5%

Price Volatility Vs. Market

How volatile is Intermolecular's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Intermolecular undervalued compared to its fair value and its price relative to the market?

2.14x

Price to Book (PB) ratio


In this section, we usually try to help investors determine whether Intermolecular is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Intermolecular has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

Future Growth

How is Intermolecular forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

133.5%

Forecasted annual earnings growth


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Intermolecular has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Intermolecular performed over the past 5 years?

28.1%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: IMI is unprofitable, but has reduced losses over the past 5 years at a rate of 28.1% per year.

Accelerating Growth: Unable to compare IMI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: IMI is unprofitable, making it difficult to compare its past year earnings growth to the Semiconductor industry (-6.2%).


Return on Equity

High ROE: IMI has a negative Return on Equity (-39.16%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: IMI is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: IMI is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is Intermolecular's financial position?


Financial Position Analysis

Short Term Liabilities: IMI's short term assets ($26.9M) exceeds its short term liabilities ($5.7M)

Long Term Liabilities: IMI's short term assets (26.9M) exceeds its long term liabilities (11.8M)


Debt to Equity History and Analysis

Debt Level: IMI is debt free.

Reducing Debt: IMI has no debt compared to 5 years ago when its debt to equity ratio was 30.7%.


Balance Sheet

Inventory Level: IMI has a high level of physical assets or inventory.

Debt Coverage by Assets: IMI's debt is not covered by short term assets (assets are -1.5119709848989E+16x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: IMI has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: IMI has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 48.2% each year


Next Steps

Dividend

What is Intermolecular's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.5%markettop25%3.7%industryaverage2.2%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate IMI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate IMI's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if IMI's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if IMI's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of IMI's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of Intermolecular's salary, the management and board of directors tenure and is there insider trading?

2.4yrs

Average management tenure


CEO

Chris Kramer (57yo)

3.1yrs

Tenure

US$2,029,000

Compensation

Mr. Christian F. Kramer, also known as Chris, has been Chief Executive Officer and President of Intermolecular, Inc. since August 4, 2016. Mr. Kramer has more than 25 years of experience as a senior techno ...


CEO Compensation Analysis

Compensation vs. Market: Chris's total compensation ($USD2.03M) is about average for companies of similar size in the US market ($USD491.38K).

Compensation vs Earnings: Chris's compensation has increased whilst the company is unprofitable.


Management Age and Tenure

2.4yrs

Average Tenure

57yo

Average Age

Experienced Management: IMI's management team is considered experienced (2.4 years average tenure).


Board Age and Tenure

2.8yrs

Average Tenure

72yo

Average Age

Experienced Board: IMI's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

BuyUS$016 May 19
Gabelli & Company Investment Advisers, Inc.
EntityCompany
Shares1,415,000
Max PriceUS$1.18
BuyUS$2,545,43116 May 19
GAMCO Investors, Inc.
EntityCompany
Shares2,168,721
Max PriceUS$1.18
SellUS$2,925,00009 May 19
Redpoint Ventures
EntityCompany
Shares2,500,000
Max PriceUS$1.17
SellUS$200,00005 Mar 19
Redpoint Ventures
EntityCompany
Shares200,000
Max PriceUS$1.00
SellUS$208,49425 Feb 19
Milfam LLC
EntityCompany
Shares189,540
Max PriceUS$1.10
SellUS$17,00625 Feb 19
Estate Of Lloyd I Miller Iii
EntityCompany
Shares15,460
Max PriceUS$1.10
SellUS$5,00421 Feb 19
Milfam LLC
EntityCompany
Shares4,569
Max PriceUS$1.10
SellUS$40921 Feb 19
Estate Of Lloyd I Miller Iii
EntityCompany
Shares373
Max PriceUS$1.10
SellUS$4,28713 Nov 18
Steven Krausz
EntityIndividual
Shares4,500
Max PriceUS$0.96

Ownership Breakdown


Management Team

  • C. Neely (65yo)

    Consultant

    • Tenure: 2.4yrs
    • Compensation: US$447.55k
  • Bill Roeschlein (49yo)

    Senior VP & CFO

    • Tenure: 2.4yrs
    • Compensation: US$785.45k
  • Chris Kramer (57yo)

    President

    • Tenure: 3.1yrs
    • Compensation: US$2.03m
  • Milind Weling

    Senior Vice President of Programs & Operations

    • Tenure: 2.5yrs
  • Joe Montano

    Senior Vice President of Customer Enablement

    • Tenure: 1.7yrs
  • Karl Littau

    Chief Technology Officer

    • Tenure: 1.5yrs

Board Members

  • Irwin Federman (83yo)

    Independent Director

    • Tenure: 14.3yrs
    • Compensation: US$59.45k
  • Ken Traub (57yo)

    Chairman of the Board

    • Tenure: 1.3yrs
    • Compensation: US$70.70k
  • George Scalise (85yo)

    Lead Independent Director

    • Tenure: 3.3yrs
    • Compensation: US$74.45k
  • Yoshio Nishi (79yo)

    Member of the Scientific Advisory Board

    • Tenure: 0yrs
  • Marv Burkett (77yo)

    Independent Director

    • Tenure: 8.3yrs
    • Compensation: US$77.78k
  • Krishna Saraswat (72yo)

    Member of the Scientific Advisory Board

    • Tenure: 0yrs
  • Chris Kramer (57yo)

    President

    • Tenure: 3.1yrs
    • Compensation: US$2.03m
  • Adam L. Scheer (47yo)

    Director

    • Tenure: 1.6yrs
    • Compensation: US$92.90k
  • Sayeef Salahuddin

    Member of the Scientific Advisory Board

    • Tenure: 0yrs
  • Matthew Furnas (31yo)

    Director

    • Tenure: 2.5yrs
    • Compensation: US$61.74k

Company Information

Intermolecular, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Intermolecular, Inc.
  • Ticker: IMI
  • Exchange: NasdaqGS
  • Founded: 2004
  • Industry: Semiconductors
  • Sector: Semiconductors
  • Market Cap: US$59.461m
  • Shares outstanding: 49.76m
  • Website: https://www.intermolecular.com

Number of Employees


Location

  • Intermolecular, Inc.
  • 3011 North First Street
  • San Jose
  • California
  • 95134
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
IMINasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDNov 2011
IMLDB (Deutsche Boerse AG)YesCommon StockDEEURNov 2011

Biography

Intermolecular, Inc. engages in the development of advanced materials using high productivity combinatorial (HPC) technology platform for the semiconductors, consumer electronics, automotive, and aerospace ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/21 00:31
End of Day Share Price2019/09/19 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.